Global Coagulation Factor Concentrates Market by Type of Coagulation Factor, Product Formulation, Application, End-User - Forecast 2024-2030- Product Image

Sale

Global Coagulation Factor Concentrates Market by Type of Coagulation Factor, Product Formulation, Application, End-User - Forecast 2024-2030

Report
181 Pages
March 2024
Region: Global
360iResearch™
ID: 5887478

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Coagulation Factor Concentrates Market size was estimated at USD 8.66 billion in 2023, USD 8.84 billion in 2024, and is expected to grow at a CAGR of 7.46% to reach USD 14.34 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Coagulation Factor Concentrates Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Coagulation Factor Concentrates Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Factor Concentrates Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bio Products Laboratory Limited, BIOGEN INC., Biotest AG., Cerus Corporation, Emergent BioSolutions Inc., Kedrion S.p.A, LFB USA, Medscape Network, Novo Nordisk A/S, Octapharma USA, Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Coagulation Factor Concentrates Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type of Coagulation Factor
- Factor IX (FIX) concentrates
- Factor VII (FVII) concentrates
- Factor VIII (FVIII) concentrates
- Factor XIII (FXIII) concentrates
Product Formulation
- Plasma-Derived Coagulation Factor Concentrates
- Recombinant Coagulation Factor Concentrates
Application
- Hemophilia Treatment
- Surgical Procedures
End-User
- Homecare Settings
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Coagulation Factor Concentrates Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Coagulation Factor Concentrates Market?
What are the technology trends and regulatory frameworks in the Coagulation Factor Concentrates Market?
What is the market share of the leading vendors in the Coagulation Factor Concentrates Market?
Which modes and strategic moves are suitable for entering the Coagulation Factor Concentrates Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Coagulation Factor Concentrates Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of hemophilia and clotting deficiencies
5.1.1.2. Increase in biotechnology R&D to develop effective coagulation factor concentrates
5.1.1.3. Inclination toward early diagnosis and treatment of diseases
5.1.2. Restraints
5.1.2.1. Contamination issues associated with the synthesis of coagulation factor concentrate
5.1.3. Opportunities
5.1.3.1. Introduction of improved coagulation factor concentrates
5.1.3.2. Significant advancements in gene therapy
5.1.4. Challenges
5.1.4.1. Stringent regulatory procedure for product approval
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Coagulation Factor Concentrates Market, by Type of Coagulation Factor

6.1. Introduction
6.2. Factor IX (FIX) concentrates
6.3. Factor VII (FVII) concentrates
6.4. Factor VIII (FVIII) concentrates
6.5. Factor XIII (FXIII) concentrates

7. Coagulation Factor Concentrates Market, by Product Formulation

7.1. Introduction
7.2. Plasma-Derived Coagulation Factor Concentrates
7.3. Recombinant Coagulation Factor Concentrates

8. Coagulation Factor Concentrates Market, by Application

8.1. Introduction
8.2. Hemophilia Treatment
8.3. Surgical Procedures

9. Coagulation Factor Concentrates Market, by End-User

9.1. Introduction
9.2. Homecare Settings
9.3. Hospitals
9.4. Specialty Clinics

10. Americas Coagulation Factor Concentrates Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Coagulation Factor Concentrates Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Coagulation Factor Concentrates Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Bayer AG
14.1.2. Bio Products Laboratory Limited
14.1.3. BIOGEN INC.
14.1.4. Biotest AG.
14.1.5. Cerus Corporation
14.1.6. Emergent BioSolutions Inc.
14.1.7. Kedrion S.p.A
14.1.8. LFB USA
14.1.9. Medscape Network
14.1.10. Novo Nordisk A/S
14.1.11. Octapharma USA, Inc.
14.1.12. Pfizer Inc.
14.1.13. Takeda Pharmaceutical Company Limited
14.1.14. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. COAGULATION FACTOR CONCENTRATES MARKET RESEARCH PROCESS
FIGURE 2. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2023 VS 2030
FIGURE 3. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COAGULATION FACTOR CONCENTRATES MARKET DYNAMICS
FIGURE 7. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2030 (%)
FIGURE 8. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2030 (%)
FIGURE 10. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. COAGULATION FACTOR CONCENTRATES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. COAGULATION FACTOR CONCENTRATES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. COAGULATION FACTOR CONCENTRATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 6. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR IX (FIX) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR VII (FVII) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR VIII (FVIII) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR XIII (FXIII) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 11. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PLASMA-DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 34. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 38. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 56. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 60. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 68. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 92. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 105. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 109. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 113. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 117. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 121. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 129. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 141. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 145. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 149. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 165. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 177. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. COAGULATION FACTOR CONCENTRATES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. COAGULATION FACTOR CONCENTRATES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. COAGULATION FACTOR CONCENTRATES MARKET LICENSE & PRICING

Companies Mentioned

Bayer AG
Bio Products Laboratory Limited
BIOGEN INC.
Biotest AG.
Cerus Corporation
Emergent BioSolutions Inc.
Kedrion S.p.A
LFB USA
Medscape Network
Novo Nordisk A/S
Octapharma USA, Inc.
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 8.84 Billion
Forecasted Market Value ( USD ) by 2030	$ 14.34 Billion
Compound Annual Growth Rate	7.4%
Regions Covered	Global
No. of Companies Mentioned	14

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Coagulation Factor Concentrates - Global Strategic Business Report

Global Hemophilia Treatment Market by Product Type (Antifibrinolytic Agents, Desmopressin, Plasma Derived Coagulation Factor Concentrates), Disease Indication (Hemophilia A, Hemophilia B, Polyethylene), Distribution - Forecast 2024-2030

Recombinant Coagulation Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

Human Coagulation Factor IV Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Coagulation Factor Deficiency - Pipeline Insight, 2024

About the Coagulation Factor Market